Share Email Print

Proceedings Paper

Radiosensitized treatment of malignant brain tumors
Author(s): Laima Bloznelyte-Plesniene M.D.
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Around 12,000 deaths from glioblastoma occurs within the European Community annually. At present, the best available treatment for malignant brain tumors results in a median survival of patients of 15 months despite surgery, radiotherapy, and chemotherapy. The purpose of this paper is to review our results of radiosensitized treatment of malignant brain tumors.

Paper Details

Date Published: 12 December 2003
PDF: 3 pages
Proc. SPIE 5287, Laser Florence 2002: A Window on the Laser Medicine World, (12 December 2003); doi: 10.1117/12.544911
Show Author Affiliations
Laima Bloznelyte-Plesniene M.D., Vilnius Univ. (Lithuania)

Published in SPIE Proceedings Vol. 5287:
Laser Florence 2002: A Window on the Laser Medicine World
Leonardo Longo; Alfons G. Hofstetter; Mihail-Lucien Pascu; Wilhelm R. A. Waidelich, Editor(s)

© SPIE. Terms of Use
Back to Top